Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning
NCT ID: NCT02952716
Last Updated: 2017-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
60 participants
INTERVENTIONAL
2016-10-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurological Sequelae in Patients With Acute Carbon Monoxide Poisoning
NCT04925297
Hyperbaric Oxygen for Carbon Monoxide Induced Chronic Encephalopathy
NCT04118491
Outcome Following Carbon Monoxide Poisoning in Children
NCT01059708
Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy
NCT06574048
Cerebral Blood Flow and Metabolism During Hypoxia and Endotoxemia
NCT00332267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention group
Human Cord Blood Mononuclear Cell will be slowly infusion three times,at one days, 30 days,at 60days.
Human cord blood mononuclear cell
The patients were treated by human cord blood mononuclear cell through subarachnoid space
hyperbaric oxygen
The patients were treated by hyperbaric oxygen
control group
hyperbaric oxygen
hyperbaric oxygen
The patients were treated by hyperbaric oxygen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Human cord blood mononuclear cell
The patients were treated by human cord blood mononuclear cell through subarachnoid space
hyperbaric oxygen
The patients were treated by hyperbaric oxygen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No serious infection, chronic diseases, diabetes and tuberculosis.
* Written informed consents were obtained from all subjects.
* Symptomatic Delayed Encephalopathy After Carbon Monoxide Poisoning.
Exclusion Criteria
* Allergic constitution, clotting disorders, autoimmune diseases and tumors.
* Pregnancy.
* Moribund patient.
* History of prior brain injury.
* History of central nervous system disease.
35 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Liaocheng People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chen shuangfeng
Central Laboratory Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shuangfeng Chen, Ph.D.
Role: STUDY_DIRECTOR
Liaocheng People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Liaocheng city people's hospital
Liaocheng, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
cell therapy for neurology
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.